Key result
In a rat model of streptozotocin-induced diabetes, progressive cardiac dysfunction over 12 weeks was associated with a significant decline in Ca2+ spark frequency and an increase in decay time constants.
Absolute Event Rate: 67.7% vs 76.1%
p-value: p=<0.05
Progressive decay of Ca2+ sparks and altered expression of Ca2+-associated proteins contribute to the time-dependent development of cardiac dysfunction in diabetic cardiomyopathy.
Hypothesis-generating in diabetic rats; leaves open whether Ca2+ spark targeting merits human trials.
BACKGROUND: Cardiac dysfunction in diabetic cardiomyopathy may be associated with abnormal Ca2+ homeostasis. This study investigated the effects of alterations in Ca2+ homeostasis and sarcoplasmic reticulum Ca2+-associated proteins on cardiac function in the development of diabetic cardiomyopathy. METHODS: Sprague-Dawley rats were divided into 4 groups (n = 12, each): a control group, and streptozotocin-induced rat models of diabetes groups, examined after 4, 8, or 12 weeks. Evaluations on cardiac structure and function were performed by echocardiography and hemodynamic examinations, respectively. Cardiomyocytes were isolated and spontaneous Ca2+ spark images were formed by introducing fluorescent dye Fluo-4 and obtained with confocal scanning microscopy. Expressions of Ca2+-associated proteins were assessed by Western blotting. RESULTS: Echocardiography and hemodynamic measurements revealed that cardiac dysfunction is associated with the progression of diabetes, which also correlated with a gradual but significant decline in Ca2+ spark frequency (in the 4-, 8- and 12-week diabetic groups). However, Ca2+ spark decay time constants increased significantly, relative to the control group. Expressions of ryanodine receptor 2 (RyR2), sarcoplasmic reticulum Ca2+-2ATPase (SERCA) and Na+/Ca2+ exchanger (NCX1) were decreased, together with quantitative alterations in Ca2+regulatory proteins, FKBP12.6 and phospholamban progressively and respectively in the diabetic rats. CONCLUSIONS: Ca2+ sparks exhibited a time-dependent decay with progression of diabetic cardiomyopathy, which may partly contribute to cardiac dysfunction. This abnormality may be attributable to alterations in the expressions of some Ca2+-associated proteins.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2014) studied Diabetic cardiomyopathy (n=48). Streptozotocin-induced diabetes vs. Citrate buffer injection (Control) was evaluated on Left ventricular ejection fraction at 12 weeks (p=<0.05). In a rat model of streptozotocin-induced diabetes, progressive cardiac dysfunction over 12 weeks was associated with a significant decline in Ca2+ spark frequency and an increase in decay time constants.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: